Editor’s Commentary: If anyone needed proof that a huge chunk of the American public is brainwashed, idiotic, or a combination of the two, one needs only look at the fact that Anthony Fauci is still listened to by so many people. This is a man who do not deserve the title of “Doctor” and should almost certainly be charged with multiple crimes, yet he continues to be perched atop the healthcare world dictating to the Biden regime what needs to be done about Covid-19.
One of his solutions has been well-documented by us and others. He’s the king of the vaccine-pushers. But there’s another solution he has been pushing since before the so-called “vaccines” were rolled out, and his connections to that solution are dubious. He’s been pushing Remdesivir and helping to suppress Ivermectin and Hydroxychloroquine. The latter two have been demonstrated to save lives. Fauci’s favorite solution/investment, Remdesivir, is questionable at best.
And yet it’s the one that’s pushed by the FDA. This is a scandal that nobody’s talking about other than a handful of doctors and journalists, including our good Dr. Joseph Mercola…
- Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, favors using remdesivir, despite a lack of science-based evidence of it being effective against COVID-19
- The antiviral prodrug is a nucleoside/nucleotide reverse transcriptase inhibitor and a close cousin to the HIV drug tenofovir used to fight the retrovirus that triggers AIDS
- Although trials with remdesivir do not back the general claims from Fauci that the drug is “highly significant” and the “new standard of care,” general approval by the FDA was given in October 2020, which boosted first quarter sales for its maker
- Conversely, ivermectin, a long-used antiparasitic drug with a known profile of safety, is effective against the virus but information is being suppressed as fear strategies are used to funnel the public into vaccination programs
In the early months of 2019, the pharmaceutical industry was under fire from legislators and the media about the exorbitant prices being charged in the U.S. for drugs. According to one poll reported by Ars Technica,1 58% of people in the U.S. held a negative view of the industry.
The price hike on one life-saving medication — EpiPen — rose from $50 in 2007 for a single autoinjector to $600 in 2018 for a pack of two.2 One reason the price rose so dramatically was that the maker, Mylan, began selling the injectors in two packs only — leaving the door open to charge whatever they felt like for that double-dose package.3
The move subsequently led to a class action lawsuit alleging “the two-pack sale of EpiPens is a pretense for charging unconscionable prices” and that Mylan is “misstating the science of EpiPen dosage in order to purportedly justify its price gouging,’ in violation of various state deceptive and unfair trade practice and consumer protection laws,” according to MarketWatch.
Profits for the drug company rose to $1.1 billion each year for the drug since it is next to impossible for people with severe allergic reactions to go without an EpiPen. But just when it looked like governmental agencies and legislators were considering looking at pricing policies, the pharmaceutical industry used the 2020 pandemic to reverse their public image when they were called upon to develop a vaccine for a viral infection at “Warp Speed.”4
Now, despite the fact the industry holds no responsibility for adverse events associated with the vaccine,5 including death, 2020 gave Big Pharma the needed impetus to overcome their lowest reputation score since public opinion of the industry began being measured in 2001.6
During 2020, Big Pharma as a whole worked hard to portray itself as a benevolent industry that poured billions of dollars into the creation of drugs and vaccines with the intent of protecting public health. As part of that group, biotech giant Gilead Sciences is no different.
The company manufactures remdesivir,7 which is the antiviral drug favored by Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, and the chief medical adviser to the president. However, while the chief medical officer of the U.S. promotes remdesivir, scientific evidence demonstrates the drug has a dark side, and it is not effective.
Fauci’s Favored Drug Has a Dark Secret
The FDA fully approved remdesivir October 22, 2020, for use in adults and children in the treatment of COVID-19.8 This came after the emergency use authorization was issued May 1, 2020, for remdesivir in patients who had “suspected or laboratory-confirmed COVID-19.”
Remdesivir is an antiviral drug that is a nucleoside/nucleotide reverse transcriptase inhibitor. It was tested in primates as a treatment for Ebola and found to have some effectiveness against the severe acute respiratory syndrome (SARS) outbreak in 2002 and the Middle East Respiratory Syndrome (MERS) outbreak in 2012.9
Before this, Gilead had produced a remarkably similar drug called tenofovir for HIV.10 Remdesivir is nearly a copy of Gilead’s HIV drug and is also a reverse transcriptase inhibitor. According to a paper published in Molecules, “Reverse transcriptase is an enzyme in the human immunodeficiency virus (HIV) and many retroviruses that convert the RNA template to DNA.”11
The enzyme helps to synthesize a strand of DNA that complements the RNA template. Several nucleoside reverse transcriptase inhibitors are anti-HIV agents.12 This may support the hypothesis that the SARS-CoV-2 virus is a chimera.
The term chimera comes from mythology and describes an organism or individual in which the body has cells from genetically distinct organisms. In Greek mythology,13 a chimera was a fire-breathing monster that had the face of a lion, the tail of a snake and the wings of a dragon. In a review of the use of remdesivir for COVID-19, one research team wrote:14
“Other clinically approved nucleoside/nucleotide analogues, such as the hepatitis C drug sofosbuvir and HIV drugs alovudine and zidovudine, have also been shown to be active against the SARS RdRp [RNA dependent RNA polymerase] in in vitro biochemical assays and might have the potential to be repurposed against COVID-19.”
The Mountain View Voice15 reports Fauci believes the remdesivir trials were reminiscent of research that had been conducted nearly 34 years ago when he and his colleagues were analyzing the human immunodeficiency virus (HIV).
The relationship between SARS-CoV-2 and human retroviruses is complex. To date, there are three retroviruses that scientists have identified that infect humans. Retroviruses are RNA genetic material that changes the host DNA. In 2019, the three known retroviruses that may cause human illness were HIV and types 1 and 2 human T-cell lymphotropic viruses.16
In “The Many Ways in Which COVID Vaccines May Harm Your Health,” you can watch my interview with Stephanie Seneff, Ph.D., and Judy Mikovits, Ph.D., where we discuss one of the more dangerous parts of SARS-CoV-2 — the spike protein envelope, common in retroviruses, that causes many of the disease challenges doctors are fighting from COVID-19.
Despite Negative Trial Results FDA Approved Remdesivir
Pharmaceutical company Gilead Sciences was given at least $70.5 million in taxpayer money to develop remdesivir, and that number may be higher.17 The recommended treatment dose for remdesivir spans five to 10 days, all of which must be administered in the hospital.18
Gilead Sciences charges the government $2,340 and private insurance $3,120,19 which is well above the drug maker’s estimated cost for production, which is between $10 and $600 for a 10-day course.20
But the price tag does not reflect the effectiveness of the drug. There were several negative trial results, and yet the FDA approved the drug anyway. A few trials were stopped early when participants experienced significant side effects. Some scientists believed the data suggested the drug could shorten recovery time.21
However, the drug has not produced adequate results or proved to reduce the potential for death in those with severe disease. Worse yet, the treatment comes with an added price tag of potential kidney damage.22
While Fauci called the results of studies that had not been peer-reviewed from a pharmaceutical-sponsored clinical trial “highly significant” and referred to remdesivir as the “new standard of care,”23 the World Health Organization had a different recommendation. Based on evidence from the SOLIDARITY trial, the WHO conditionally recommended against using remdesivir in hospitalized patients.24
Fauci’s support of an antiviral drug that hasn’t lived up to the hype helped support the company’s falling revenues. During the first quarter of 2021, remdesivir grossed $1.5 billion in sales, helping boost Gilead’s total bottom line of $6.4 billion in revenue during that same quarter — a 16% increase over the first quarter of 2020. But when revenue for remdesivir was excluded, revenue actually plummeted 11%, at a disappointing $4.9 billion.25
Remdesivir Not Backed by Results
The data from science trials for remdesivir have been disappointing. One study published in The New England Journal of Medicine26 concluded that the drug worked better than a placebo and so was stopped early for benefit. However, as Peter Gotzsche from The Institute for Scientific Freedom wrote, this benefit was not a reduction in mortality from COVID-19, but rather shortened hospital days.27
The placebo-controlled study demonstrated the drug could reduce hospital stays from 15 days to 11 days. Yet, other physicians were finding the drug was keeping people in the hospital longer. Although Dr. George Ralls with Orlando Health reported they saw positive benefits with the drug, he also attributed it to longer hospital stays in order to complete the course of treatment.28
As I reported in “The New COVID-19 Medication Isn’t Backed by Results,” in the middle of the study (April 20, 2020), the researchers changed the primary outcome measures so patients only had to meet three of an original eight categories,29 and none of the three included measurement of mortality.
In the last update to Clinical Trials30 before publication, the researchers had one primary outcome measurement — time to recovery. The idea for the drug was to keep people from dying, but the researchers stopped measuring that important outcome.
In another study published in The Lancet,31 researchers evaluated remdesivir in patients with severe COVID-19. The primary endpoint measurement was how long it took for clinical improvement. The drug was stopped early because 12% of the patients experienced adverse events and researchers found there were no statistically significant clinical benefits.
Just before the release of the studies in The New England Journal of Medicine and The Lancet, Bloomberg32 reported the WHO accidentally posted results of a third study. The summary was removed, but details showed “the drug wasn’t associated with patients getting better more quickly; and 13.9% of patients getting the drug died, versus 12.8% getting standard care.”
Ivermectin Is Effective but Intentionally Suppressed
While researchers using remdesivir struggle to identify and prove the drug is effective against COVID-19, data clearly show ivermectin can prevent it and when used early can keep people from progressing to the hyper inflammatory phase of the disease.
In fact, ivermectin can even be used late in the disease to help critically ill patients recover. The drug has a long history of use as an antiparasitic33 and has a known safety profile as compared to remdesivir, which has a short history of use.
In the early months of COVID-19, a group of physicians formed the Frontline COVID-19 Critical Care Alliance (FLCCC).34 The collaboration of the five founding physicians in the group resulted in a protocol that can be used in the hospital and another that can be used as an outpatient. Each of the five founding members has treated critical illness for decades.
The two protocols are available for download on the FLCCC alliance website in multiple languages.35,36 Ivermectin was added to the outpatient and inpatient protocols. Although many of the drugs used in the protocols are now accepted standards of care in many places, the same is not true of ivermectin.
It is important to remember that as others clamor for randomized controlled trials to demonstrate that ivermectin is effective, these become more or less unethical when you can see from clinical evidence that something is working, and you know you’re condemning the control group to poor outcomes or death.
In fact, this is the same argument vaccine makers are using now to justify the elimination of control groups by giving everyone the vaccine.
While the WHO recommended that remdesivir not be used in hospitalized patients based on a systematic review and meta-analysis of pooled data from four randomized trials, the evidence37 they used to recommend that ivermectin not be used in patients with COVID-19 except in clinical trials is based on what they admit is a “high degree of uncertainty.”38
You can read more about the benefits of using ivermectin and how this information is being purposefully suppressed in “COVID, Ivermectin and the Crime of the Century.” In the article is a video from DarkHorse podcast host Bret Weinstein, Ph.D., in which he interviews Dr. Pierre Kory about the importance of early treatment of COVID-19 and the shameful censoring of information about ivermectin.
It’s no small irony, then, that YouTube deleted this interview, which is why I embedded a Bitchute version. How this interview could possibly be labeled as misinformation is a mystery, considering the entire conversation is about published research and they are both credentialed medical science experts.
Steps to Help Reduce the Severity of the Disease
As I’ve discussed, fear is contagious and is being used to control your behavior. One strategy initially used to funnel the public into vaccination programs revolved around using PCR testing to demonstrate a rising number of cases. However, as I’ve written several times, PCR testing does not accurately diagnose an active infection.
During lockdown, many people put on pandemic pounds that contribute to increasing your risk of getting sick. Instead of depending on drugs and vaccines, I recommend you proactively work to support your immune system using strategies that evidence demonstrates reduces your risk of severe disease.
It has become evident that optimizing your vitamin D level may be the least expensive, easiest and most beneficial strategy to minimize your risk. Making simple lifestyle changes to normalize your blood sugar levels can also help reduce your risk of heart disease, Type 2 diabetes and viral infections such as COVID-19 and flu.
Comorbid conditions that are related to severe disease with COVID-19 include cardiovascular disease and Type 2 diabetes. In “Nearly Half of American Adults Have Cardiovascular Disease,” I summarize strategies that improve the microcirculation in your heart as well as mitochondrial function and insulin resistance, which are related to strong heart health.
It is difficult to control Type 2 diabetes when you rely strictly on medication and do not change the underlying lifestyle factors that have caused the problem. If properly addressed, Type 2 diabetes can be entirely reversible in most people. In “Diabetes Can Increase the Complications of COVID-19,” I discuss some of those dietary and lifestyle choices and offer suggestions for change.
- 1 Ars Technica, September 14, 2019
- 2 Ars Technica, August 17, 2018
- 3 MarketWatch September 7, 2016
- 4 U.S. Department of Defense, Operation Warp Speed
- 5 CNBC, December 17, 2020
- 6 European Pharmaceutical Review, November 3, 2020
- 7 Gilead Sciences, Veklury
- 8 FDA, October 22, 2020
- 9 Biochemical and Biophysical Research Communications, 2021;538:145
- 10 ACS Central Science, 2020;6(5)
- 11, 12 Molecules, 2020;25(10)
- 13 Britannica, Chimera
- 14 ACS Central Science, 2020;6(5) Other Nucleoside Candidates
- 15 Mountain View Voice, April 29, 2020
- 16 Minessota Department of Health, Retroviruses that May Cause Human Illness
- 17 Public Citizen, May 7, 2020
- 18 FDA, Highlights of Prescribing Information
- 19 CNBC, June 29, 2020
- 20 Institute for Clinical and Economic Review, November 10, 2020
- 21 New England Journal of Medicine, 2020;383
- 22 International Journal of Infectious Diseases, 2020; doi.org/10.1016/j.ijid.2020.06.093
- 23 Alliance of Human Research Protection, May 6, 2020
- 24 World Health Organization, Therapeutics and COVID-19: Living Guidelines
- 25 Fierce Pharma, April 30, 2021
- 26 New England Journal of Medicine, 2020; DOI: 10.1056/NEJMoa2007764
- 27, 29 Scientific Freedom, June 1, 2020
- 28 WFTV 9, June 23, 2020
- 30 Clinical Trials, December 9, 2020
- 31 The Lancet, 2020;395(10236):P1569
- 32 Bloomberg, April 23, 2020
- 33 The Journal of Antibiotics, 2017;70
- 34 Frontline COVID-19 Critical Care Alliance
- 35 FLCCC Alliance I-MASK+ Protocol
- 36 FLCCC MATH+ Hospital Protocol
- 37 The BMJ, 2020;370 doi.org/10.1136/bmj.m2980
- 38 World Health Organization, Therapeutic and COVID-19 Living Guidelines, 7.1 Ivermectin/ Justification
New Conservative Network Seeks Crowdfunding Help
They say we have to go big or go home. We’re trying to go big and bring the patriotic truth the the nation, but we need help.
Readers may or may not realize that over the past year, we’ve been bringing more conservative news and opinion outlets under our wing. Don’t take our expansion as a sign of riches; all of the “acquisitions” have been through sweat and promises of greater things to come for all involved. As a result, we’ve been able to bring together several independent media sites under a unified vision of preventing America from succumbing to the progressive, “woke,” Neo-Marxist ideologies that are spreading like wildfire across America.
The slow and steady reopening of America is revealing there was a lot more economic hardship brought about from the Covd-19 lockdowns than most realize. While we continue to hope advertising dollars on the sites go up, it’s simply not enough to do things the right way. We are currently experiencing a gap between revenue and expenses that cannot be overcome by click-ads and MyPillow promos alone (promo code “NOQ” by the way).
To overcome our revenue gap and keep these sites running, our needs fluctuate between $3000-$7000 per month. In other words, we’re in the red and hemorrhaging.
The best way you can help us grow and continue to bring the truth to the people is by donating. We appreciate everything, whether a dollar or $10,000. Anything brings us closer to a point of stability when we can hire writers, editors, and support staff to make the America First message louder. Our Giving Fuel page makes it easy to donate one-time or monthly. Alternatively, you can donate through PayPal as well.
As the world spirals towards radical progressivism, the need for truthful journalism has never been greater. But in these times, we need as many conservative media voices as possible. Please help keep NOQ Report and the other sites in the network going.
Survival ProTip: Some of the best survival gear can be found at camping retailers. With summer fading, take advantage of sales on camping gear that can help you survive if the crap hits the fan.
Thank you and God Bless,
Will America-First News Outlets Make it to 2023?
Things are looking grim for conservative and populist news sites.
There’s something happening behind the scenes at several popular conservative news outlets. 2021 was bad, but 2022 is proving to be disastrous for news sites that aren’t “playing ball” with the corporate media narrative. It’s being said that advertisers are cracking down, forcing some of the biggest ad networks like Google and Yahoo to pull their inventory from conservative outlets. This has had two major effects. First, it has cooled most conservative outlets from discussing “taboo” topics like Pandemic Panic Theater, voter fraud, or The Great Reset. Second, it has isolated those ad networks that aren’t playing ball.
Certain topics are anathema for most ad networks. Speaking out against vaccines or vaccine mandates is a certain path to being demonetized. Highlighting voter fraud in the 2020 and future elections is another instant advertising death penalty. Throw in truthful stories about climate change hysteria, Critical Race Theory, and the border crisis and it’s easy to understand how difficult it is for America-First news outlets to spread the facts, share conservative opinions, and still pay the bills.
Without naming names, I have been told of several news outlets who have been forced to either consolidate with larger organizations or who have backed down on covering certain topics out of fear of being “canceled” by the ad networks. I get it. This is a business for many of us and it’s not very profitable. Those of us who do this for a living are often barely squeaking by, so loss of additional revenue can often mean being forced to make cuts. That means not being able to cover the topics properly. Its a Catch-22: Tell the truth and lose the money necessary to keep telling the truth, or avoid the truth and make enough money to survive. Those who have chosen survival simply aren’t able to spread the truth properly.
We will never avoid the truth. The Lord will provide if it is His will. Our job is simply to share the facts, spread the Gospel, and educate as many Americans as possible while exposing the forces of evil.
To those who have the means, we ask that you please donate. We have options available now, but there is no telling when those options will cancel us. We have our GivingFuel page. There have been many who have been canceled by PayPal, but for now it’s still an option. Your generosity is what keeps these sites running and allows us to get the truth to the masses. We’ve had great success in growing but we know we can do more with your assistance.
Thank you, and God Bless!
Covid variant BA.5 is spreading. It appears milder but much more contagious and evades natural immunity. Best to boost your immune system with new Z-Dtox and Z-Stack nutraceuticals from our dear friend, the late Dr. Vladimir Zelenko.